Complement-Based Drug Development Summit leaderboard
  • Friday, September 4, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 543

Author

Pharma Journalist 9038 posts 0 comments

Novavax Advances Development of Novel COVID-19 Vaccine

Feb 27, 2020
Novavax, Inc. announced progress in its efforts to develop a novel vaccine to protect against coronavirus disease COVID-19. Novavax has produced and is currently assessing multiple…
Read More...

Sandoz to keep prices stable for potential coronavirus drugs

Feb 27, 2020
Sandoz is making a public commitment to ensure stable pricing for a basket of essential medicines the company markets, which may help to treat coronavirus patients, amid growing…
Read More...

Gilead Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of…

Feb 26, 2020
Gilead Sciences announced the initiation of two Phase 3 clinical studies to evaluate the safety and efficacy of remdesivir in adults diagnosed with COVID-19 (novel coronavirus). These…
Read More...

Janssen Pharmaceutical exclusive interview released ahead of Pre-filled Syringes East Coast 2020

Feb 26, 2020
SMi Reports: Alie Jahangir from Janssen Pharmaceutical to speak at Pre-Filled Syringes East Coast returning to Boston USA, in April. With SMi’s highly sought after Pre-Filled…
Read More...

ImmunOs Therapeutics Selects ProBioGen for Development and Large-Scale Manufacturing Services

Feb 26, 2020
ProBioGen AG announced that ImmunOs Therapeutics AG has signed a Manufacturing Services Agreement for their novel platform of multitasking biologics. ProBioGen will support ImmunOs in…
Read More...

Perrigo and Catalent Announce FDA Approval of Perrigo’s AB-Rated Generic Version of ProAir HFA

Feb 26, 2020
Perrigo Company plc and its partner, Catalent Pharma Solutions, announced that the U.S. Food and Drug Administration (FDA) has approved Perrigo’s abbreviated new drug application for…
Read More...

Report on the 8th edition of BioFIT in Marseille | December 10 & 11, 2019

Feb 26, 2020
BioFIT 2019: A great first edition in Marseille For its first phocean edition, BioFIT confirms its status as the leading European partnering event for early-stage deals and…
Read More...

Pharmaceutics International (Pii) Expands Aseptic Filling Capabilities with Fully Robotic Filling…

Feb 26, 2020
Pharmaceutics International, Inc. (Pii), a pharmaceutical contract development and manufacturing organization (CDMO), announces the expansion of its aseptic filling capacity and…
Read More...

Lysogene Receives FDA Fast Track Designation for LYS-SAF302 Gene Therapy in MPS IIIA

Feb 26, 2020
Lysogene, a pioneering Phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast…
Read More...

TwinStrand Biosciences Launches Duplex Sequencing Technology

Feb 26, 2020
TwinStrand Biosciences announced the launch of TwinStrand Duplex Sequencing Technology kits at the annual Advances in Genome Biology and Technology (AGBT) General Meeting in Marco…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry
  • Cipla Licenses HER2 Cancer Drug TQB2102 Across Emerging Markets
  • FDA Approves BESREMi for Essential Thrombocythemia After 30 Years
  • Teva Discusses Lower Medicaid Drug Prices With Trump Administration
  • Kazia Therapeutics Raises $40 Million to Advance Paxalisib Trials

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

World ADC Awards 2026 Shortlist Announced, Recognizing…

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.